Rainier Group Investment Advisory LLC increased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 35.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,800 shares of the pharmacy operator’s stock after buying an additional 1,000 shares during the quarter. Rainier Group Investment Advisory LLC’s holdings in Walgreens Boots Alliance were worth $249,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in WBA. Victory Capital Management Inc. grew its stake in shares of Walgreens Boots Alliance by 5.1% in the 4th quarter. Victory Capital Management Inc. now owns 47,910 shares of the pharmacy operator’s stock valued at $3,479,000 after purchasing an additional 2,314 shares during the last quarter. Gratus Capital LLC lifted its holdings in shares of Walgreens Boots Alliance by 8.3% in the 4th quarter. Gratus Capital LLC now owns 89,943 shares of the pharmacy operator’s stock valued at $6,532,000 after buying an additional 6,863 shares during the period. KBC Group NV lifted its holdings in shares of Walgreens Boots Alliance by 342.0% in the 4th quarter. KBC Group NV now owns 696,554 shares of the pharmacy operator’s stock valued at $50,584,000 after buying an additional 538,958 shares during the period. First Business Financial Services Inc. lifted its holdings in shares of Walgreens Boots Alliance by 28.3% in the 4th quarter. First Business Financial Services Inc. now owns 9,098 shares of the pharmacy operator’s stock valued at $661,000 after buying an additional 2,007 shares during the period. Finally, Girard Partners LTD. lifted its holdings in shares of Walgreens Boots Alliance by 51.6% in the 4th quarter. Girard Partners LTD. now owns 4,358 shares of the pharmacy operator’s stock valued at $316,000 after buying an additional 1,483 shares during the period. Hedge funds and other institutional investors own 60.30% of the company’s stock.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the completion of the transaction, the director now directly owns 13,679 shares of the company’s stock, valued at $896,795.24. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 14.80% of the company’s stock.
Several research firms have recently commented on WBA. Royal Bank of Canada set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Friday, February 16th. Bank of America began coverage on Walgreens Boots Alliance in a report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target for the company. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. Barclays began coverage on Walgreens Boots Alliance in a report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target for the company. Finally, BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, February 28th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $81.90.
Walgreens Boots Alliance traded up $0.59, hitting $64.50, during midday trading on Thursday, Marketbeat.com reports. 34,204 shares of the stock were exchanged, compared to its average volume of 5,481,014. The stock has a market cap of $63.53 billion, a PE ratio of 12.63, a P/E/G ratio of 1.03 and a beta of 1.14. Walgreens Boots Alliance Inc has a fifty-two week low of $61.56 and a fifty-two week high of $83.89. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.45 and a current ratio of 0.90.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company had revenue of $33.02 billion during the quarter, compared to analysts’ expectations of $32.20 billion. During the same period in the previous year, the firm posted $1.36 earnings per share. The business’s revenue for the quarter was up 12.1% compared to the same quarter last year. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.96 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th were issued a $0.40 dividend. The ex-dividend date of this dividend was Thursday, May 17th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.48%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 31.37%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.